Conduit Pharmaceuticals And Murphy Canyon Acquisition Corp. Announce Completion Of Business Combination
Portfolio Pulse from Benzinga Newsdesk
Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. (NASDAQ:MURF) have completed their previously announced business combination. Conduit will commence trading on September 25, 2023, under ticker symbol 'CDT' for its common stock and 'CDTTW' for its warrants on The Nasdaq Global Market and The Nasdaq Capital Market respectively. The pro forma enterprise value at the debut of trading will be approximately $720 million. MURF has changed its name to Conduit Pharmaceuticals Inc. and will begin trading under the new ticker symbols.
September 22, 2023 | 1:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Murphy Canyon Acquisition Corp. (NASDAQ:MURF) has completed its business combination with Conduit Pharmaceuticals. The company has changed its name to Conduit Pharmaceuticals Inc. and will commence trading under new ticker symbols 'CDT' and 'CDTTW'.
The completion of the business combination and the change of name and ticker symbols are significant events for Murphy Canyon Acquisition Corp. These changes could attract new investors and potentially increase the stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100